Skip to content

A study on development and evaluation of individual cognitive behavioral therapy for substance dependence and addictive behaviors

A study on development and evaluation of individual cognitive behavioral therapy for substance dependence and addictive behaviors - A study on development and evaluation of individual cognitive behavioral therapy for substance dependence and addictive behaviors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000051449
Enrollment
240
Registered
2023-06-26
Start date
2021-06-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use Disorder Gambling Disorder

Interventions

The developed individual cognitive behavioral therapy for about four months. The existing group cognitive behavioral therapy for about four months.

Sponsors

National Center of Neurology and Psychiatry
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Those who continue treatment for alcohol use, drug use, or gambling disorder at a research institution. 2) Those who meet the criteria for the diagnosis of substance use disorder and gambling disorder according to the DSM-5. 3) Those who do not have comorbidities or mental or physical problems that should be treated in preference to the disorders described in 2) . 4) Those who do not need to be hospitalized and are able to receive outpatient treatment. 5) Those who have received an explanation about this research and voluntarily agreed to it. 6) A person who is 20 years of age or older at the time of obtaining consent.

Exclusion criteria

Exclusion criteria: Patients whose primary physician determines that treatment with individual or collective CBT is inappropriate.

Design outcomes

Primary

MeasureTime frame
Number of days of use (implementation) in the last 30 days.

Secondary

MeasureTime frame
TMD score (POMS2 shortened version)

Countries

Japan

Contacts

Public ContactAyumi Kondo

National Institute of Mental Health Department of Drug Dependence Research National Institute of Mental Health Department of Drug Dependence Research

a-kondo@ncnp.go.jp042-346-1954

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026